期刊文献+

前列腺癌血清PSA与磁共振波谱变化的相关性研究 被引量:3

Correlation between Serum PSA and MRS in Patients with Prostate Cancer
下载PDF
导出
摘要 目的:探讨前列腺癌患者磁共振波谱(MRS)改变与血清中总前列腺特异抗原(TPSA)、游离前列腺特异抗原(fPSA)及两者比值(f/T)的相关性。方法:30例经活检证实为前列腺癌患者TPSA、fPSA及f/T值为参数,将3组数据分别与前列腺癌兴趣区所得(Cho+Cr)/Cit值的平均数进行相关性分析。结果:CC/C比值与血清总PSA浓度平均值呈正相关关系(相关系数r=0.750),差异具有显著性意义(P<0.01);与血清游离PSA浓度呈正相关关系(相关系数r=0.814),差异具有显著性意义(P<0.05);与f/T值呈正相关关系(相关系数r=0.189),差异无显著性意义(P=0.318>0.05)。结论:CC/C值与血清总PSA浓度及游离PSA浓度呈正相关,而CC/C值较高患者更易于发现和确定前列腺内发生代谢改变的区域,因此PSA值较高患者行MRS更具临床意义。 Objective:To investigate the correlation between the magnetic resonance spectroscopy(MRS) change and the three sets of clinical laboratory data including total prostate-specific antigen(TPSA),free prostate specific antigen(fPSA) and the ratio between fPSA and TPSA(f/T).Methods:In 30 cases of prostate cancer confirmed by biopsy,TPSA,fPSA and f/T parameters were determined after MRS examination.The correlation between each set of the clinical laboratory data and the average value of(Cho+Cr)/Cit obtained in the specific interest areas was analyzed.Results:Using the method of MRI and MRS,30 cases of patients were diagnosed as having prostate cancer,of which 29 cases had MRS changes.The results of statistical studies showed that the correlation between the value of CC/C and the average concentration of serum of total PSA was positive(r=0.750,P〈0.05);the correlation between CC/C and the concentration of serum free PSA was positive(r=0.814,P〈0.05);the correlation between the value of CC/C and f/F value was positive(r=0.189,P=0.3180.05),without statistical significance.Conclusion: It is easier to identify the abnormal metabolic regions in patients with prostate cancer with higher CC/C value,and the clinical value of MRS in patients with higher PSA value is of greater help to clinical management.
出处 《放射学实践》 北大核心 2009年第12期1324-1326,共3页 Radiologic Practice
关键词 前列腺肿瘤 磁共振波谱学 磁共振成像 前列腺特异抗原 Prostate neoplasms Magnetic resonance spectroscopy Magnetic resonance imaging Prostate specific antigen
  • 相关文献

参考文献11

  • 1Catalone W J, Southwick PC, Slawin KM, et al. Comparison of Percent Free PSA, PSA Density, and Age Specific PSA Cutoffs for Prostate Cancer Detection and Staging[J ]. Urology, 2000,56 ( 2), 255-260.
  • 2Scheidler J, Hricak H, Vigneron DB, et al. Prostatecancer : Localization with Three Dimensional Proton MR Spectroscopic Imaging Clinicopathologic Study[J]. Radiology,1999,213(2) :473-480.
  • 3Mccormack RT, Rittenhouse HG. Molecular Forms of Prostate Specific Anigen and the Human Kallikrein Gene Family: a New Era[J]. Urology,1995,45(5) :729-744.
  • 4Grossklaus DJ ,Shappell SB,Gautam S,et al. Ratio of Free-to-total Prostate Specific Antigen Correlates with Tumor Volume in Patients with Increased Prostate Specific Antigen[J]. J Urol, 2001, 165(2) :455-458.
  • 5Brawer MK. Prostate Specific Antigen: Current Status[J]. CA Cancer J Clin,1999,49(5) :264-281.
  • 6秦海燕,白人驹,王希明,赵新.3D^1HMRSI对外周带前列腺癌鉴别诊断价值的初步研究[J].医学影像学杂志,2005,15(11):978-982. 被引量:4
  • 7Kurhanewiez J, Vigneron DB, Males RG, et al. The Prostate: MR Imaging and Spectroscopy. Pesent and Future [J]. Radiol Clin North Am,2000,38(1) :115-138.
  • 8Swindle P, McCredie S, Russell P, et al. Pat-hologic Characterization of Human Prostate MR Spectroscopy[J]. Radiology, 2003, 228(1) :144-151.
  • 9夏同礼,邓方明,冯陶.血清前列腺特异性抗原增高的病理基础[J].中华医学杂志,1994,74(5):306-308. 被引量:22
  • 10Babaian RJ. Monoconal Prostate- specific Antigen in Untreated Prostate Cancer. Relationship to Clinical Stage and Grade[J]. Cancer, 1991,67(8) : 2200-2206.

二级参考文献21

  • 1[1]Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR imaging of the in situ human prostate with high (0.24-0.7 cm3) spatial resolution[J]. Radiology, 1996, 198(3): 795-805.
  • 2[2]Cornud F, Flam T, Chauveinc, et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results[J]. Radiology, 2002, 224(1): 203-210.
  • 3[5]Bartolozzi C, Crocetti L, Menchi I, et al. Endorectal magnetic resonance imaging in local staging of prostate carcinoma[J]. Abdom Imaging, 2001, 26(2): 111-122.
  • 4[6]Lowry M, Liney GP, Turnbull LW, et al. Quantification of citrate concentration in the prostate by proton magnetic spectroscopy: zonal and age-related differences[J]. Magn Reson Med, 1996, 36(3): 252-358.
  • 5[7]Kurhanewicz J, Swanson MG, Wood PJ, et al. Magnetic resonance imaging and spectroscopic imaging: improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials[J]. Urology, 2001, 57(suppl 4A): 124-128.
  • 6[8]Hahn P, Smith ICP, Leboldus L, et al. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra[J]. Cancer Research, 1997, 57(6): 3398-3401.
  • 7[9]Schiebler ML, Tomaszewski JE, Bezzi M, et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings[J]. Radiology, 1989, 172(1): 131-137.
  • 8[10]Muramoto S, Uematsu H, Kimura H, et al. Differential of prostate cancer from benign prostate hypertrophy using dual-echo dynamic contrast MR imaging[J]. Euro J Radio, 2002, 44(1): 52-58.
  • 9张文标,中华医学检验杂志,1993年,16卷,166页
  • 10Kurhanewicz J, Vigneron DB, Hricak H, et al.Three-dimensional ^1H MR spectroscopy of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution[J]. Radiology,1996,198:795-805.

共引文献117

同被引文献48

  • 1王洛夫,江军,靳风烁,朱方强,李彦峰,姜庆,孙中义.前列腺癌144例临床分析[J].第三军医大学学报,2004,26(11):1026-1027. 被引量:2
  • 2李飞宇,王霄英,丁建平,周良平,肖江喜,蒋学祥.良性前列腺增生的MRS与血清PSA、PSAD相关性初步研究[J].中国医学影像技术,2004,20(8):1164-1167. 被引量:7
  • 3李飒英,陈敏,周诚,陈锴.前列腺癌患者血清PSA与磁共振波谱代谢改变的相关性研究[J].临床放射学杂志,2006,25(9):855-857. 被引量:1
  • 4叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 5Catalona W J, Richie J P, Ahmann F R, et al. Comparison ot dgtat rectal examination and serum prostate specific antigen in the early de- tection of prostate cancer: results of a muhicenter clinical trial of 6, 630 men[J]. I Uml, 1994, 151(5): 1283-1290.
  • 6Challaeombe B, Dasgupta P, Patel U, et al. Recognizing and manag- ing the complications of prostate biopsy [ J ]. BJU Int, 2011, 108 (8) : 1233 - 1234.
  • 7Raja J, Ramachandran N, Munneke G, et al. Current status of tran- srectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer[J]. Clin Radiol, 2006, 61 (2) : 142 -53.
  • 8Kirkham A P, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? [ J ]. Eur Urol, 2006, 50(6) : 1163 -1174.
  • 9Kurhanewicz J, Vigneron D B, Males R G, et al. The prostate: MR imaging and spectroscopy. Present and future [ J ]. Radiol Clin North Am, 2000, 38(1): 115- 138, viii-ix.
  • 10Aekerstaff E, Pflug B R, Nelson J B, et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectrosco- py subsequent to malignant transformation of human prostatic epithelial cells[J]. Cancer Res, 2001, 61 (9) : 3599 -3603.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部